- Home
- LRMR vs KRNY Comparison
LRMR vs KRNY Comparison
Compare LRMR & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LRMR | KRNY |
|---|---|---|
| Founded | N/A | 1884 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.8M | 495.9M |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LRMR | KRNY |
|---|---|---|
| Price | $3.46 | $8.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $16.50 | $9.25 |
| AVG Volume (30 Days) | ★ 1.8M | 271.9K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 5.45% |
| EPS Growth | N/A | ★ 130.22 |
| EPS | N/A | ★ 0.46 |
| Revenue | N/A | ★ $2,580,000.00 |
| Revenue This Year | N/A | $3.89 |
| Revenue Next Year | $1,816.14 | $17.52 |
| P/E Ratio | ★ N/A | $17.87 |
| Revenue Growth | N/A | ★ 36.00 |
| 52 Week Low | $1.80 | $5.76 |
| 52 Week High | $6.42 | $8.50 |
Technical Indicators
Market Signals| Indicator | LRMR | KRNY |
|---|---|---|
| Relative Strength Index (RSI) | 35.07 | 57.51 |
| Support Level | $3.14 | $7.77 |
| Resistance Level | $3.78 | $8.27 |
| Average True Range (ATR) | 0.28 | 0.17 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 22.79 | 89.69 |
Price Performance
Historical ComparisonAbout LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.